Literature DB >> 12115191

Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway.

Nicoletta Ronda1, Rita Gatti, Roberto Giacosa, Elena Raschi, Cinzia Testoni, Pier Luigi Meroni, Carlo Buzio, Guido Orlandini.   

Abstract

OBJECTIVE: Fibroblast activation is a crucial event in the development of systemic sclerosis (SSc). Antifibroblast autoantibodies (AFAs), detectable in the sera of SSc patients, are able to induce a proinflammatory phenotype on cultured fibroblasts. This study was undertaken to investigate the mechanisms of the interaction between AFAs and living fibroblasts.
METHODS: We coupled to fluorescein 1) IgG purified from AFA-positive and AFA-negative SSc sera (as assessed by cellular enzyme-linked immunosorbent assay) and 2) single healthy donor and pooled normal IgG. The interaction of IgG with living cultured fibroblasts from healthy individuals and from a patient with SSc was visualized by real-time confocal microscopy. Intracellular colocalization of caveolin and internalized AFA-positive IgG was assessed by immunofluorescence.
RESULTS: AFA-positive IgG bound to living fibroblasts and was internalized with a cytoplasmic fibrillar pattern, in contrast to AFA-negative IgG. In the IgG tested, no correlation with antinuclear antibody activity was found. Preincubation of fibroblasts with normal IgG did not affect internalization. Internalized AFA-positive IgG colocalized with caveolin, and internalization was entirely inhibited by disassembling fibroblast caveolae with filipin.
CONCLUSION: The finding that both normal and pathologic fibroblasts specifically internalized AFA-positive, but not AFA-negative, IgG demonstrates that AFAs in SSc patient sera interact with constitutively expressed membrane molecules on fibroblasts, via an Fc-independent mechanism. The results of colocalization and inhibition experiments suggest that microdomains containing caveolin are involved in the interaction between AFAs and fibroblasts. These data, together with the reported ability of AFAs to activate fibroblasts, provide evidence for a role of AFAs in the pathogenesis of SSc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115191     DOI: 10.1002/art.10362

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

Review 1.  Intravenous immunoglobulin and fibrosis.

Authors:  Vered Molina; Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 2.  Fibrosis--a lethal component of systemic sclerosis.

Authors:  Yuen Yee Ho; David Lagares; Andrew M Tager; Mohit Kapoor
Journal:  Nat Rev Rheumatol       Date:  2014-04-22       Impact factor: 20.543

3.  Alteration of fibroblast phenotype by asbestos-induced autoantibodies.

Authors:  Jean C Pfau; Sheng'ai Li; Sara Holland; Jami J Sentissi
Journal:  J Immunotoxicol       Date:  2011-04-04       Impact factor: 3.000

Review 4.  Pathogenic roles of autoantibodies in systemic sclerosis: Current understandings in pathogenesis.

Authors:  Jean-Luc Senécal; Sabrina Hoa; Roger Yang; Martial Koenig
Journal:  J Scleroderma Relat Disord       Date:  2019-09-09

Review 5.  Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis.

Authors:  Alfred Grassegger; Gabriela Pohla-Gubo; Margret Frauscher; Helmut Hintner
Journal:  Wien Med Wochenschr       Date:  2008

6.  [Retroperitoneal fibrosis].

Authors:  S Burkhardt Soares; S Kukuk; A S Brandt; A Fehr; S Roth
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

Review 7.  Antifibrosis: to reverse the irreversible.

Authors:  Ziv Paz; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

8.  Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.

Authors:  Elena Raschi; Daniela Privitera; Caterina Bodio; Paola Adele Lonati; Maria Orietta Borghi; Francesca Ingegnoli; Pier Luigi Meroni; Cecilia Beatrice Chighizola
Journal:  Arthritis Res Ther       Date:  2020-11-09       Impact factor: 5.156

9.  IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts.

Authors:  Mathieu C Tamby; Amélie Servettaz; Nicolas Tamas; Joseph Reinbolt; Frédéric Caux; Olivier Meyer; Yannick Allanore; André Kahan; Loïc Guillevin; Luc Mouthon
Journal:  Biologics       Date:  2008-09

10.  Peptide Sharing Between Viruses and DLX Proteins: A Potential Cross-Reactivity Pathway to Neuropsychiatric Disorders.

Authors:  Guglielmo Lucchese; Benjamin Stahl
Journal:  Front Neurosci       Date:  2018-03-21       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.